TITAN PHARMACEUTICAL INC
TTP
TTP was delisted on the 24th of December, 2008.
1 hedge funds and large institutions have $278K invested in TITAN PHARMACEUTICAL INC in 2015 Q4 according to their latest regulatory filings, with funds opening new positions, 1 increasing their positions, 0 reducing their positions, and 1 closing their positions.
13% more capital invested
Capital invested by funds: $245K → $278K (+$33K)
50% less funds holding
Funds holding: 2 → 1 (-1)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GS
Gagnon Securities
New York
|
+$7.05K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HNB
Huntington National Bank
Columbus,
Ohio
|
-$2K |
TTP Hedge Fund Activity: Q4 2015 in Review
1 of the 3,812 institutional investors tracked by Wall St. Rank reported a position in TITAN PHARMACEUTICAL INC (TTP) for Q4 2015, worth a combined $278K — up 13% from $245K a quarter earlier.
Sellers outnumbered buyers: 1 fund closed out of TTP and 0 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 1 added.
The largest buyer was Gagnon Securities, adding an estimated $7.05K. The largest seller was Huntington National Bank, exiting entirely with an estimated $2K sold.
- 1 institutional investor held TITAN PHARMACEUTICAL INC (TTP) as of Q4 2015, down from 2 in Q3 2015.
- Funds reported $278K of TITAN PHARMACEUTICAL INC stock for Q4 2015, up 13% quarter-over-quarter.
- 0 funds opened new TITAN PHARMACEUTICAL INC positions in Q4 2015 and 1 closed out, a net change of -1 holder.
- The largest TITAN PHARMACEUTICAL INC buyer in Q4 2015 was Gagnon Securities, an estimated $7.05K added.
- The largest TITAN PHARMACEUTICAL INC seller in Q4 2015 was Huntington National Bank, an estimated $2K sold.
Based on aggregated 13F filings for Q4 2015.